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Objective:This retrospective study examines the relationship between the renal resistive index (RI) and blood pressure and
renal function response after open and percutaneous intervention for atherosclerotic renovascular disease (AS-RVD).
Methods: From March 1997 to December 2005, 86 patients (46 women, 40 men; mean age, 68  10 years) underwent
renal duplex sonography (RDS), including main renal artery and hilar vessel Doppler interrogation, before treatment of
AS-RVD. Of these, 56 patients had open operative repair, and 30 had percutaneous intervention. The RI (1–[EDV/
PSV]) was calculated from the kidney with the highest peak systolic velocity (PSV). Hypertension response was graded
from preprocedural and postprocedural blood pressure measurements and medication requirements. Renal function
response was graded by a >20% change in estimated glomerular filtration rate (eGFR) calculated from the serum
creatinine concentration.
Results: Comorbid conditions, baseline blood pressure, and preoperative renal function were not significantly different
between open and percutaneous groups. Baseline characteristics that differed between the percutaneous vs open group
were higher mean age (71 11 years vs 67 9 years; P .05), kidney length (11.3 1.3 cm vs 10.7 1.2 cm; P .02),
proportion of patients with RI>0.8 (50% vs 21%; P .01), and proportion of bilateral AS-RVD (37% vs 80%; P< .01).
After controlling for preintervention blood pressure and extent of repair, postoperative eGFR differed significantly for
RI <0.8 or >0.8 when all patients (P  .003) and percutaneous intervention (P  .008) were considered. Specifically,
eGFR declined from preprocedure to postprocedure in the patients with RI >0.8 after percutaneous repair and in the
group analyzed as a whole. Neither systolic nor diastolic pressure after intervention demonstrated an association with RI.
Considering all patients and both groups, multivariable proportional hazards regression models demonstrated that RI
was predictive of all-cause mortality. RI was the most powerful predictor of death during follow-up (hazard ratio, 6.7;
95% confidence interval, 2.6-17.2; P < .001).
Conclusion: After intervention for AS-RVD, RI was associated with renal function, but not blood pressure response. A
strong, independent relationship between RI and mortality was observed for all patients and both treatment groups.
(J Vasc Surg 2009;49:148-55.)Occlusive renovascular disease (RVD) has been recog-
nized as a cause of secondary hypertension and excretory
renal insufficiency (ie, ischemic nephropathy) in both chil-
dren and adults. In children with severe renal artery lesions
in combination with severe hypertension, empiric renal
artery intervention presumes that the incidence of severe
essential hypertension in the child is essentially nil. How-
ever, atherosclerotic renovascular disease (AS-RVD) in as-
sociation with hypertension and excretory renal insuffi-
ciency in the adult does not ensure blood pressure or renal
function benefit with correction of the renal artery lesion.
In fact, when intervention is applied to all lesions, the
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148correction of AS-RVD has been associated with a beneficial
blood pressure response in roughly half of patients.1-6 As a
consequence, studies that would accurately and reliably
define the functional significance of AS-RVD would have
clinical utility.
Studies to evaluate the physiologic significance of AS-
RVD have included plasma renin activity, captopril renog-
raphy, split renal function tests, selected renal vein renin
assays, and others. Recently, studies have described signif-
icant correlation between Doppler-derived parameters
from renal duplex sonography (RDS) of segmental renal
vessels and the renal parenchyma, and response to interven-
tion for AS-RVD.7-12 Although we have found RDS to be
both accurate and reliable for the determination of hemo-
dynamically significant main renal artery stenosis or occlu-
sion, we have not used features of the Doppler spectrum to
select patients for intervention.13-15 Given the overall ac-
curacy of RDS as a screening study for anatomic disease, if
the Doppler spectral analysis could provide indication of
both the hemodynamic and the functional significance of
AS-RVD, the utility of RDS would be further enhanced.
This retrospective review examines the association be-
tween Doppler-derived parameters from the segmental re-
nal arteries in hypertensive patients with AS-RVD and with
or without renal insufficiency. Specific aims of the review
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renal function response, and segmental Doppler spectral
analysis after open operative repair; (2) determine the asso-
ciation with segmental Doppler spectral analysis after per-
cutaneous renal artery intervention; and (3) relate segmen-
tal Doppler features to long-term patient survival.
METHODS
Patient population. Patients who underwent serial
RDS at Wake Forest University Baptist Medical Center
were identified from a vascular registry approved by the
Institutional Review Board. From March 1997 to Decem-
ber 2005, 662 patients had serial RDS (Appendix Table A1,
online only). Within this group, 439 had no intervention.
The remaining 223 patients underwent renal revasculariza-
tion, and AS-RVD and preprocedural segmental Doppler-
derived data were available for analysis for 86 (38.6%). This
group formed the study sample for this report.
Selection criteria for renal artery intervention in the
open repair group included (1) patients with severe hyper-
tension taking multiple medications, (2) hypertension
complicated by flash pulmonary edema or malignant hyper-
tension, and (3) patients with ischemic nephropathy in the
setting of bilateral RVD or RVD in a solitary kidney. In
contrast, all percutaneous interventions were performed by
nonsurgeons and reflect patient selection criteria particular
to those physician groups (Appendix Table A2, online
only).
Hospital records, clinic records, and RDS results were
reviewed for all patients. Measured clinical outcomes in-
cluded blood pressure and number of antihypertensive
medications. Glomerular filtration rates were estimated
(eGFR) using the abbreviated Modification of Diet in
Renal Disease equation.16 Blood pressure response after
the intervention was estimated, as previously described.17
Renal function response was considered improved, un-
changed, or worsened by a20% change in eGFR after the
intervention. Mortality was established using a National
Death Index search combined with follow-up medical
record review and phone contact.
Renal duplex sonography. The technique of RDS
has been described in detail.13,14 Briefly, the patient was
placed in a supine position and studied using a 2.25- or
3.0-MHz ultrasound probe. The aorta and its branches
were imaged in both sagittal and longitudinal planes. The
left renal vein was imaged in longitudinal section and used
as a reference to identify the aortic origins of the main renal
arteries. While maintaining an angle of insonation 60°,
Doppler samples were taken from each renal artery from the
aortic origin to the renal hilum.
Renal artery peak systolic velocity (PSV) and end dia-
stolic velocity (EDV) were estimated from the spectral
analysis of Doppler-shifted signals. The RDS was consid-
ered positive for significant RVD when there was a focal
increase in PSV 1.8 m/s or when no Doppler signal was
obtainable (renal artery occlusion). The resistive index (RI)
[1–(EDV/PSV)] was calculated using Doppler frequency
shifts from the segmental (ie, hilar) arteries of the kidneywith the highest main renal artery PSV, which would cor-
relate to the kidney with the greater stenosis. Radermacher
et al8 have reported a differential response to renal artery
intervention for patients with a RI 0.8 vs RI 0.8.8 We
used these values in our analysis.
Statistical analysis. Descriptive statistics were com-
puted, including means and standard deviations of contin-
uous variables, and frequencies and percents of categoric
variables. Comparisons between dichotomous subgroups
(open vs percutaneous repair and RI0.8 vs RI0.8) were
performed using t tests for continuous factors and 2 tests
or the Fisher exact test (where appropriate due to small
expected cell counts) for categoric factors. Associations
between the preoperative RI and blood pressure and renal
function responses to the operation were examined using
analysis of covariance controlling for preoperative outcome
(blood pressure or renal function) and extent of disease
(unilateral or bilateral AS-RVD). Postoperative survival was
estimated by life-table methods. Multivariable associations
between risk factors and survival were examined using
proportional hazards regression models. A stepwise model
selection procedure was performed where factors were en-
tered one-by-one, starting with the most significant, until
all factors remaining significant at the   0.10 level were
included.
RESULTS
Demographics. The cohort consisted of 46 women
and 40men, with a mean age of 68 10 years, 56 of whom
had open operative repair and 30 had percutaneous inter-
vention. Patient demographics and preoperative character-
istics are depicted in Table I. There were no significant
differences between open and percutaneous repair where
gender, ethnic distribution, renal insufficiency, history of
coronary artery disease, hypertension and baseline blood
pressure, diabetes mellitus, hyperlipidemia, peripheral vas-
cular disease, or tobacco abuse were considered. The per-
cutaneous group, compared with the open group, demon-
strated a higher mean age (71  11 vs 67  9 years; P 
.05), a greater proportion of patients with RI0.8 (50% vs
21%; P .01), a greater mean kidney length (11.3 1.3 vs
10.7  1.2 cm; P  .02), and a lower proportion of
bilateral AS-RVD (37% vs 80%; P  .01; Table I). The
average length of time between intervention and blood
pressure response measurement was 23 13 weeks (range,
3-67 weeks). The average time from renal revascularization
to measured renal function response was 20  12 weeks
(range, 1-52 weeks).
The RI was examined in the group as a whole and
separately for the percutaneous and open repair subgroups.
A RI 0.8 vs 0.8 was used to compare the treatment
groups with respect to baseline characteristics, renal revas-
cularization outcomes, and survival. Differences in the fol-
lowing preoperative factors between RI groups were exam-
ined: age (at intervention), gender, race, blood pressure
and number of blood pressure medications; renal function,
renal length, and maximum renal artery PSV; histories of
hypertension, diabetes, coronary artery disease, peripheral
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repair type (unilateral or bilateral) and completeness of
repair (unilateral vs bilateral repair in patients with bilateral
AS-RVD).
There was no observed difference in the maximum
renal artery PSV (cm/s) between the percutaneous and
open repair groups (2.56  0.72 [range, 2.10-3.20] vs
2.49  1.02 [range, 1.79-3.30] or between the RI 0.8
and RI 0.8 groups (2.51  0.92 [range 1.90-3.30] vs
2.51 0.95 [range, 2.00-3.30]). No significant differences
between RI subgroups were observed in the percutaneous
group; however, mean age and diastolic pressure at the time
of open repair were significantly different according to
RI 0.8 and 0.8 (Table II).
Treatment. Eighty-six patients underwent renal artery
intervention for hemodynamically significant AS-RVD. Of
those, 56 patients had open operative repair consisting of
renal artery repair alone in 39 or renal artery repair com-
bined with aortic procedures in 17. Renal artery repairs
included anatomic in 15 and extra-anatomic renal artery
bypass in 2, transaortic endarterectomy in 3, and renal
endarterectomy in 19. Combined aortic procedures in-
cluded renal artery bypass in 11 or endarterectomy in 7 in
addition to aneurysm repair in 10, aortic endarterectomy in
4, and aortoiliac/aortofemoral bypass for occlusive disease
in 3. In the percutaneous treatment group (n  30), four
patients had angioplasty alone, whereas the remainder un-
Table I. Descriptive statistics of demographic characterist
(percutaneous or open repair)
Factor Overall (N 
Age at intervention, y 68  10
Female gender 46 (54)
African American race 8 (9)
Pre-op systolic BP, mm Hg 183  29
Pre-op diastolic BP, mm Hg 92  17
Pre-op antihypertensive drugs, No. 2.9  1.4
Pre-op history of hypertension 82 (97)
Pre-op serum creatinine, mg/dL 1.8  1.1
Pre-op eGFR, mL/min/1.73m2 49  30
Pre-op dialysis dependent 2 (2)
Pre-op renal length, cm 10.9  1.3
Pre-op max B-segment PSV, m/s 2.51  0.9
Pre-op RI from side with max PSV-B 0.75  0.0
Pre-op RI 0.8 27 (31)
History of diabetes 20 (24)
History of TIA/CVA 32 (39)
History of coronary disease 59 (69)
History of PVD 30 (35)
Lipid-lowering drug 47 (55)
Bilateral renal artery disease 56 (65)
Incomplete disease repair d 9 (11)
BP, Blood pressure; CVA, cerebrovascular accident; eGFR, estimated glom
transient ischemic attack; PSV, peak systolic velocity; RI, resistive index; PV
aTable entries are mean SD for continuous factors and frequency (%) for d
groups: bP  .05; cP  .01.
dUnilateral repair, bilateral disease.derwent primary placement of endoluminal stents. BilateralRA intervention was performed in 45 patients with bilateral
AS-RVD (37 open; 8 percutaneous), including three inter-
ventions for patients with solitary kidneys. Unilateral inter-
vention for patients with bilateral AS-RVD (ie, incomplete
repair) was performed in nine patients, six open (11%) and
three percutaneous (10%).
Outcomes. Controlling for preintervention renal
function, RI 0.8 vs 0.8 demonstrated a statistically
significant association with change in eGFR after percuta-
neous intervention and when the entire group was consid-
ered. Statistical significance was observed for the group as a
whole and in patients undergoing percutaneous interven-
tion, but not in the open operative group. Patients with a
RI0.8 who underwent percutaneous intervention exhib-
ited a significant decline in eGFR (preoperative eGFR,
51.7  7.2 vs postoperative, 40.3  40.3; P  .03). No
other subgroups exhibited significant preoperative to post-
operative change in eGFR. For open repair, the association
between the RI and difference in eGFR approached, but
did not achieve, statistical significance (P .06; Table III).
Systolic and diastolic blood pressures were both signif-
icantly improved after intervention, whether considered as
an entire group or within the percutaneous and open
subgroups. However, blood pressure response demon-
strated no association with a RI 0.8 or 0.8 after renal
artery intervention. Neither the overall group, the percuta-
neous group, nor the open operative group demonstrated
d preoperative factors, overall and by intervention type
Type of interventiona
Percutaneous (n  30) Open (n  56)
71  11 67  9
13 (43) 33 (59)
2 (7) 6 (11)
186  31 181  28
92  17 92  17
3.3  1.3 2.8  1.4
28 (94) 54 (98)
1.6  0.8 1.8  1.3
51  23 47  33
0 (0) 2 (4)
11.3  1.3b 10.7  1.2b
2.56  0.72 2.49  1.02
0.77  0.08 0.74  0.08
15 (50)c 12 (21)c
10 (33) 10 (19)
12 (41) 20 (37)
23 (77) 36 (66)
8 (27) 22 (40)
19 (63) 28 (51)
11 (37)c 45 (80)c
3 (10) 6 (11)
r filtration rate by Modification of Diet in Renal Disease equation; TIA,
ripheral vascular disease.
omous factors. Tests for differences in means or proportions between repairics an
86)a
3
9
erula
D, pe
ichotsignificant differences in mean postoperative systolic or
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(Table IV).
Overall, at mean follow-up of 57.6  26.2 months
(median, 57.6; range, 2.6–114.1 months), 27 patients had
died, and a RI 0.8 vs 0.8 was predictive of all-cause
mortality (Fig 1). This association was observed for the
entire group (hazard ratio [HR], 4.8; 95% confidence
interval [CI], 2.0-11; P  .001) and when the percutane-
ous (HR, 5.7; 95% CI, 1.1-28; P  .03) and open repair
groups (HR, 4.8; 95% CI, 1.6-14; P .005) were analyzed
separately.
During follow-up, RI was the most powerful predictor
of death (HR, 6.7; 95% CI, 2.6-17; P  .001) after
controlling for comorbid atherosclerotic risk factors (coro-
Table II. Demographic characteristics and preoperative fa
Factor
All patientsa
RI 0.8
(N  27)
RI 0.
(N  59
Age at intervention, y 73  6b 66  1
Female gender 16 (59) 30 (51
African American race 2 (7) 6 (10
Pre-op systolic BP, mm Hg 187  32 181  2
Pre-op diastolic BP, mm Hg 88  20 94  1
Pre-op antihypertensive drugs, No. 3.3  1.4 2.8  1
Pre-op history of hypertension 26 (100) 56 (95
Pre-op serum creatinine, mg/dL 1.7  0.9 1.8  1
Pre-op eGFR, mL/min/1.73m2 46  25 50  3
Pre-op renal length, cm 11.1  1.2 10.8  1
Pre-op max B-segment PSV, m/s 2.51  0.95 2.51  0
History of diabetes 8 (31) 12 (21
History of TIA/CVA 7 (27) 25 (44
History of coronary disease 21 (81) 38 (64
History of PVD 7 (31) 22 (37
Lipid-lowering drug 12 (46) 35 (59
Bilateral renal artery disease 14 (52) 42 (71
BP, Blood pressure; CVA, cerebrovascular accident; eGFR, estimated glom
transient ischemic attack; PSV, peak systolic velocity; RI, resistive index; PV
aTable entries are mean standard deviation for continuous factors and freq
between resistive index (RI 0.8 and RI 0.8) groups: bP  .01; cP  .05
Table III. Estimated glomerular filtration rate response
to surgery by preoperative resistive index
Repair type RI group No.
eGFR, mean  SEM,
mL/min/1.73m2
PaPre-op Post-op
All patients
combined
RI 0.8 27 45.6  4.9 40.9  3.5 .003
RI 0.8 59 49.9  4.1 53.9  2.3
Percutaneous RI 0.8 15 51.7  7.2 40.3  3.2 .008
RI 0.8 15 49.5  4.8 53.7  3.2
Open repair RI 0.8 12 38.1  5.8 41.3  5.9 .061
RI 0.8 44 50.0  5.3 54.1  3.0
eGFR, Estimated glomerular filtration rate; RI, resistive index; SEM, stan-
dard error of the mean.
aAnalysis of covariance P comparing postoperative eGFR between RI groups
controlling for preoperative eGFR and extent of repair (unilateral or bilat-
eral).nary artery disease and peripheral vascular disease) andblood pressure response to intervention, which were se-
lected for inclusion in amultivariablemodel (Table V). This
increased risk of death was similar for both percutaneous
intervention and open repair groups (Fig 2).
Removing patients who underwent combined renal
and aortic repairs from the analysis did not significantly
change the results.
DISCUSSION
An examination of our center’s experience with early
hypertension and renal function response to open operative
intervention for AS-RVD has suggested that hyperten-
sion cure was associated with survival free of dialysis-
dependence. Moreover, early incremental improvement in
renal function has demonstrated significant and inde-
pendent association with dialysis-free survival, especially
among patients with renovascular renal insufficiency (ie,
ischemic nephropathy).18,19 For those patients with severe
hypertension who underwent open operative management,
no survival benefit was demonstrated for patients with
significant improvement in hypertension compared with
those unchanged.19 In addition, only patients with an
incremental increase in excretory renal function measured
at 3 weeks demonstrated improved survival free of dialy-
sis.19 In patients with ischemic nephropathy, renal func-
tion unchanged was equivalent to renal function worsened
when mortality and risk of dialysis dependence were con-
sidered.18 Consequently, a study that could define both the
presence of hemodynamically significant AS-RVD, as well
predict the physiologic significance of the lesion (ie, the
hypertension and function response to correction), would
by resistive index groups
Percutaneous interventiona Open repaira
RI 0.8
(n  15)
RI 0.8
(n  15)
RI 0.8
(n  12)
RI 0.8
(n  44)
73  6 69  14 71  5c 65  9c
9 (60) 4 (27) 7 (58) 26 (59)
0 (0) 2 (13) 2 (18) 4 (9)
196  33 176  26 177  29 182  27
91  24 90  8 84  13* 95  18c
3.3  1.4 3.3  1.2 3.2  1.5 2.6  1.3
15 (100) 13 (87) 11 (100) 43 (98)
1.6  1.0 1.6  0.5 1.9  0.7 1.8  1.4
52  28 50  19 38  20 50  35
11.4  1.3 11.3  1.3 10.8  1.0 10.6  1.3
2.42  0.82 2.71  0.60 2.63  1.12 2.45  1.01
5 (33) 5 (33) 3 (27) 7 (16)
4 (27) 8 (57) 3 (27) 7 (16)
12 (80) 11 (73) 9 (82) 27 (61)
4 (27) 4 (27) 4 (36) 18 (41)
7 (47) 12 (80) 5 (46) 23 (52)
4 (27) 15 (7) 10 (83) 35 (80)
r filtration rate by Modification of Diet in Renal Disease equation; TIA,
ripheral vascular disease.
(%) for dichotomous factors. Tests for differences in means or proportionsctors
8
)
1b
)
)
7
6
.3
)
.2
2
.3
.92
)
)
)
)
)
)
erula
D, pe
uencyhave important clinical utility.
ration rate between RI groups controlling for preoperative estimated glomerular
CI, Confidence interval; HR, hazard ratio.
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modynamic significance of main renal artery lesions and
provideDoppler-shifted data from segmental hilar, arcuate,
and interlobar intraparenchymal vessels.13,14 Recent stud-
ies from select patient populations have demonstrated
strong associations between Doppler-derived measures
from the renal parenchyma and the severity of hyperten-
sion, the risk of progressive renal failure, and the risk of
death.8-10,12,20,21 Moreover, we have demonstrated strong
associations between Doppler-derived measures from the
Table IV. Blood pressure response to surgery by preopera
Repair type BP, mean  SEM, mm Hg RI
All patients combined SBP R
R
DBP R
R
Percutaneous SBP R
R
DBP R
R
Open repair SBP R
R
DBP R
R
DBP, Diastolic blood pressure; RI, resistive index; SBP, systolic blood press
aAnalysis of covariance P comparing postoperative estimated glomerular filt
filtration rate and extent of repair (unilateral or bilateral).
Fig 1. Long-term postoperative survival by preoperative resistive
index (RI) groups with RI 0.8 vs RI 0.8. P value for signifi-
cance of RI frommultivariable model including history of coronary
artery disease, history of peripheral vascular disease, change in
number of blood pressure medications, and blood pressure
response.renal parenchyma and the severity of elevated blood pres-Fig 2. Long-term postoperative survival by preoperative resistive
index (RI) groups with RI 0.8 vs RI 0.8 and intervention
(percutaneous or open repair). Broken curves indicate point attive resistive index
group No. Pre-op Post-op Pa
I 0.8 27 187.4  6.2 142.9  4.3 .492I 0.8 59 180.7  3.5 139.2  2.9
I 0.8 27 87.9  3.8 71.4  2.1 .141I 0.8 59 93.7  2.1 75.6  1.4
I 0.8 15 195.8  8.5 141.6  6.5 .969I 0.8 15 176.3  5.7 142.0  6.5
I 0.8 15 91.1  6.2 67.8  3.2 .062I 0.8 15 90.3  2.1 76.8  3.2
I 0.8 12 176.9  8.5 143.7  6.3 .472I 0.8 44 182.2  4.1 138.5  3.3
I 0.8 12 83.8  3.6 76.7  2.9 .646I 0.8 44 94.8  2.7 75.2  1.5
ure; SEM, standard error of the mean.Table V. Results of stepwise variable selection procedure
for predictors of long-term postoperative survival for all
85 patients (22 deaths)
Variable selected HR (95% CI) P
Pre-op resistive index 0.8 6.7 (2.6-17.2) .001
History of coronary disease 5.2 (1.2-22.9) 0.029
History of peripheral vascular disease 2.2 (0.9-5.3) 0.081
No. of antihypertensive meds pre-op
to post-op 0.6 (0.4-0.9) 0.026
No change in blood pressure
response 4.2 (1.3-13.0) 0.013which survival estimate standard error exceeds 10%.
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hort of elderly Americans.15
This retrospective review of patients with severe hyper-
tension, with or without renal insufficiency, who under-
went open operative repair or percutaneous intervention
demonstrated no apparent association between the RI and
hypertension response. However, incremental change in
renal function after percutaneous intervention demon-
strated a significant association with the RI. In addition, a
very strong association was observed between the preoper-
ative RI and all-cause mortality on follow-up regardless of
treatment group. In patients with severe hypertension with
or without renal insufficiency and AS-RVD, a RI 0.8 was
associated with a greater than sixfold risk of death com-
pared with patients with a preoperative RI 0.8. This
relationship was observed for the entire group and in both
the open operative group and percutaneous intervention
group. A RI0.8 was the strongest predictor of follow-up
mortality of any covariate examined in multivariable analysis.
Features of Doppler spectral analysis taken from both
segmental hilar renal arteries and from the interlobar and
arcuate arteries from the renal parenchyma have been sug-
gested to reflect severity of interstitial fibrosis as well as
glomerular and arteriolar sclerosis.22-24 The assumption
that the RI reflects renovascular resistance and is a surrogate
marker for renal damage has been suggested by several
authors, but few studies have correlated the RI with his-
topathologic findings in the kidney. Ikee et al25 examined
the RI in 52 patients aged 15 years whose microscopic
specimen included more than four glomeruli for evalua-
tion. Their study examined Doppler spectral analysis per-
formed in 33 patients the day before renal biopsy. In
univariate analysis, all histopathologic parameters demon-
strated a statistically significant association with the RI.
However, only arteriolar sclerosis demonstrated a signifi-
cant and independent association with the RI in multivari-
able analysis. At 57 months of follow-up, progressive renal
impairment was associated with an increased RI.
Earlier reports described an inverse correlation between
serum creatinine and the main renal artery (RA) end dia-
stolic ratio (EDR), calculated as [EDR  (RA – EDV)/
(RA –PSV)], the reciprocal of the RI.26 These same authors
used amodel of sequential microsphere embolization of the
canine kidney to demonstrate relationships between main
renal artery EDR and increasing grades of renal parenchy-
mal embolization and increased vascular resistance.26
When these grades of EDR where applied clinically, signif-
icant differences in EDR were defined among healthy,
hypertensive, and atherosclerotic patients. Moreover, a
number of investigators have reported that a decreased
EDR and an increased renal artery RI are associated with
acute tubular necrosis and vascular rejection in transplant
recipients.27-29 Considered collectively, these data would
support the notion that extrarenal and intrarenal Doppler
measures correlate with intrarenal arteriolar sclerosis and
these measures might predict both renal function and hy-
pertension response to renal artery intervention.A predictive role for the RI was suggested by Raderma-
cher et al8 in a prospective cohort study of 131 patients
treated between 1994 and 1999 for renal artery stenosis
associated with hypertension. Of these, the RI was0.8 in
96 and 0.8 in 35. After renal revascularization, 73% of
patients with an RI 0.8 had a decrease in mean arterial
blood pressure of 10%. This contrasted sharply with
patients demonstrating a RI0.8 before revascularization.
In this latter group, only 3% had a decrease in hypertension
and 80% had a decline in creatinine clearance. Within the
group with a RI 0.8, 46% became dialysis-dependent
during a mean follow-up of 32 months.
In addition, Cohn et al10 demonstrated relationships
between intrarenal spectral analysis and hypertension/renal
function outcome after renal revascularization. Among 23
patients who underwent 31 interventions, 21 were treated
for AS-RVD. The EDR defined from the renal parenchyma
demonstrated a significant and independent association
with improved blood pressure response and improved renal
function response when EDR 0.3. No patient with EDR
of 0.3 demonstrated improved renal function.
In contrast, our patient group demonstrated a statisti-
cally significant relationship between incremental change in
renal function but not hypertension response. The sub-
group of patients who had percutaneous intervention dem-
onstrated a statistically significant association with de-
creased renal function and a RI 0.8. No significant
association was found between renal function response and
a RI 0.8. Moreover, a striking independent relationship
between the RI and mortality on follow-up was observed
regardless of treatment group.
Other authors have reported the relationship between
renal parenchymal Doppler spectral analysis and cardiovas-
cular outcomes.30,31 In a select group of 566 hypertensive
patients without clinical evidence of atherosclerotic vascu-
lar disease, a RI 0.7 correlated with increased carotid
artery intima–medial thickness, left ventricular mass index,
and echocardiographic evidence of diastolic dysfunction.30
Associations between microvascular disease and extrarenal
vascular beds and adverse cardiovascular events have also
been examined. Changes in retinal microcirculation graded
by ophthalmoscopy and fluorescein angiography have been
associated with clinical and subclinical manifestations of
cardiovascular disease.32-34 In keeping with the significant
increase in mortality we observed with a RI 0.8, there
appears to be increasing evidence that measures of micro-
vascular disease in a variety of organ systems correlate with
an increased risk of adverse cardiovascular events and death
typically associated with large vessel atherosclerotic disease.
Although this study provides several interesting find-
ings, it has several limitations. The patients included in the
retrospective review were selected on the basis of more than
two RDS studies performed in our vascular laboratory. The
original intent was to examine the natural history of
AS-RVD among hypertensive patients with suspected renal
artery disease. When the 662 patients were first selected,
each patient was felt free of renal artery intervention. On
close review of the original data set, this report describes a
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but also had intervention at some point during follow-up.
As a result, this group reflects only a portion of patients who
underwent intervention for AS-RVD during the study pe-
riod who had RDS for comparison.
The RI was not used to select patients for intervention;
this was examined in a purely retrospective manner. This
resulted in asymmetry between the open and percutaneous
repair groups with respect to the RI. Within the percutane-
ous group, a significantly higher proportion of patients had
a RI0.8 (50% vs 21% in the open repair group; P .01).
This could have contributed to type II error with respect to
the observed lack of association between the RI and renal
function results in the open repair group.
In additionwithin the percutaneous group, different phy-
sician specialties referred patients for intervention and per-
formed the catheter-based intervention. As a consequence,
the criteria for renal artery intervention within this group
cannot be clearly defined. In contrast, specific selection criteria
as described earlier were used in the open repair group, and all
procedures were performed by a single group of surgeons.
This selection bias may have further compounded the study
limitations inherent to a retrospective review.
Moreover, the incomplete data set may have limited our
power to examine preoperative associationswith theRI and its
relationship with clinical response. More definitive examina-
tion of theRI and its role in predicting response to renal artery
intervention awaits results fromongoing prospective random-
ized trials from our group and the Renal Atherosclerotic
Revascularization Evaluation Study (RAVE).11
CONCLUSION
In light of these limitations, how should these RI
data affect decisions regarding intervention for AS-RVD?
Rather than including or excluding patients for renal artery
intervention, the RI should be considered in the context of
other features affecting blood pressure and renal function
response. Other associations with beneficial blood pressure
response and recovery of renal function after primary inter-
vention for AS-RVD have included site of renal artery
disease and extent of repair, rate of decline in renal func-
tion, presence of diabetes mellitus, severity of hypertension,
and severity of excretory renal insufficiency. In combina-
tion with negative features of blood pressure benefit and
renal function recovery, the association of a RI 0.8 with
increasedmortalitymay argue formedicalmanagement rather
than open or percutaneous intervention for AS-RVD.
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Dr J. Sheppard Mondy (Savannah, Ga). In the spirit of full
disclosure, I must admit that I was a Wake Forest vascular fellow,
but the following comments represent the intellectual effort of my
partner, Jerry Cohn, edited only slightly for style. I would like to
thank the society for the privilege of discussing this presentation,
and wish to thank the authors’ for timely provision of the manu-
script for my review.
Percutaneous interventions of the renal artery for atheroscle-
rotic lesions have dramatically increased over the last 10 years, due
in part to technological advances and the focus of nonvascular
surgeons on the peripheral circulation. Current medical literature
is abounding with reports that tout the high technical success of
renal interventions, the significant blood pressure responses, and
freedom from dialysis following stent placement.
Despite the contemporary zeal for renal stenting, previously
published reports from the Wake Forest group and others demon-
strate a much more modest benefit to either percutaneous inter-
vention or surgery for blood pressure control and ischemic ne-
phropathy. In fact, it could be argued that over half of the renal
artery stents placed today confers no clinical benefit to the patient.
A sound prognostic tool is needed, therefore, to predict who
benefits from renal artery intervention, and who does not.
In this latest report, the authors have analyzed the clinical
utility of renal resistive index in patients undergoing largely surgi-
cal interventions over an 8-year period for atherosclerotic lesions.
They found that low resistance in the treated kidney preoperatively
predicts a significant improvement in eGFR [estimated glomerular
filtration rate] at 3 weeks in all patients studied, and in the
subgroup of patients undergoing percutaneous intervention. No
such benefit in blood pressure response was achieved regardless of
the measured intrarenal resistance. Perhaps most importantly, re-
sistive index was highly correlated with all cause mortality in all
groups.
The authors stopped short in their manuscript from endorsing
the resistive index as an important prognostic tool to guide clini-
cians to offer intervention versus medical management in patients
with renal atherosclerosis. I would submit however that in light of
this data, preoperative assessment of the resistance of the renal
parenchyma should be undertaken by all clinicians who perform
renal interventions in order to maximize clinical outcomes.
I would like to ask the authors the following questions: First,sure response and renal function in the subgroup of patients
undergoing open repair, this did not reach statistical significance.
What factors do you think account for this lack of significance?
Second, improvements in GFR must persist for true renal
salvage and freedom from dialysis.With the known inferior patency
of percutaneous interventions over open repairs, how are percuta-
neous interventions followed up at your institution to ensure
durable patency?
Third, have you had the experience of restudying these kid-
neys after repairs and does the subsequent resistive index change in
these kidneys?
Finally, given your recent findings, what guides you currently
to recommend open versus percutaneous intervention for a patient
with ischemic nephropathy?
I wish to congratulate the authors on an important and
insightful analysis of renal resistance predicting success or failure in
atherosclerotic renal interventions, and once again thank the soci-
ety for the privilege of the floor.
Dr Teresa A. Crutchley. With respect to the first question
about why the open repair group did not achieve statistical signif-
icance between the two resistive index groups for the eGFR, this
was driven by the lack of renal function decline in the RI [resistive
index] 0.8 group compared to the 0.8 group. In contrast, the
percutaneous and overall group showed statistically significant
differences based on resistive index, and this was related to a
significant renal function decline noted after intervention in pa-
tients with an RI 0.8 in these two groups.
With respect to the second question about how we follow-up
our percutaneous repairs, we perform a duplex on the day of
intervention, and then at 6 weeks, 3 months, 6 months, 1 year, and
annually thereafter. As far as the resistive index change in the
kidneys postoperatively, we have not looked at that specifically, but
it is a very interesting question and we will examine that in the
future.
Regarding your final question, we decide between open vs
percutaneous repair based upon a variety of factors. We consider
the age and comorbidities of the patient, with advanced age and
poor LV [left ventricular] function being independent predictors
of perioperative morbidity and mortality. Generally, in relatively
younger patients without prohibitive comorbidities, we prefer
open repair given the better results with respect to renal function
response, blood pressure response, and patency.
 .05.
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Factor
Comparison of patients
artery inte
No. With
Age at intervention, yb 223 64  14
Female gender 223 137 (61)d
African American race 223 23 (10)c
Pre-op systolic BP, mm Hg 209 170  31c
Pre-op diastolic BP, mm Hg 209 88  16
History of hypertension 214 205 (96)
Pre-op serum creatinine, mg/dL 175 1.7  1.0d
Pre-op eGFR, mL/min/1.73m2 175 52  30c
Renal insufficiency, SCr 1.8 mg/dL 175 57 (33)
Pre-op renal length (cm) 214 10.6  1.3
Pre-op max B-segment PSV, m/s 213 2.41  0.98c
History of diabetes 212 51 (24)c
History of TIA/CVA 210 76 (36)
History of coronary disease 212 126 (59)
History of PVD 211 55 (26)c
On lipid-lowering medication 209 109 (52)
Bilateral renal artery disease 223 103 (46)c
BP, Blood pressure; eGFR, estimated glomerular filtration rate by Modific
peripheral vascular disease; SCr, serum creatinine; TIA, transient ischemic a
aPatients excluded because of missing data for one or more key parameters
renal artery disease.
bAge at first scan for patients not intervened.
Tests for differences in means or proportions between groups: cP  .01; dPeristics and preoperative factors by sampled groups
with vs without renal
rvention
Comparison of intervened patients in
analysis vs those excluded from analysis a
No. Without No. Included No. Exclude
439 64  12 86 68  10c 137 61  16c
439 224 (51)d 86 46 (54)d 137 91 (66)d
439 115 (26)c 86 8 (9) 137 15 (11)
300 158  30c 86 183  29c 126 169  32c
300 87  17 86 92  17 126 90  17
424 410 (97) 86 82 (97) 129 123 (95)
409 1.5  0.8d 86 1.8  1.1 89 1.6  1.0
409 61  38c 83 49  30d 89 55  30d
409 112 (27) 86 31 (36) 89 26 (29)
430 10.7  1.3 82 10.9  1.3d 132 10.5  1.3d
429 1.51  0.82c 86 2.51  0.93 127 2.33  1.01
412 177 (43)c 84 20 (24) 128 31 (24)
406 156 (38) 83 32 (39) 127 44 (35)
413 285 (69) 85 59 (69)d 127 67 (53)d
391 67 (17)c 85 30 (35)d 126 25 (20)d
410 211 (52) 85 47 (55) 124 62 (50)
159 45 (28)c 86 56 (65)d 137 56 (41)d
ation of Diet in Renal Disease equation; CVA, cerebrovascular accident; PVD,
ttack.
(resistive index, blood pressure, renal function) or because of nonatherosclerotic
1
1
1
1
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groups (0.8 vs 0.8)
Stratum 1: Preoperative resistive index 0.8
Follow-up, mon Censored Survival Failure Survival SE No. failed No. left
0.000 1.0000 0 0 0 59
12.057 0.9831 0.0169 0.0168 1 58
17.906 * . . . . . . . . . 1 57
19.318 0.9658 0.0342 0.0238 2 56
25.002 0.9486 0.0514 0.0289 3 55
26.776 * . . . . . . . . . 3 54
28.255 * . . . . . . . . . 3 53
28.715 0.9307 0.0693 0.0335 4 52
29.634 * . . . . . . . . . 4 51
31.639 0.9124 0.0876 0.0375 5 50
31.737 * . . . . . . . . . 5 49
32.230 * . . . . . . . . . 5 48
35.581 * . . . . . . . . . 5 47
36.600 * . . . . . . . . . 5 46
37.552 * . . . . . . . . . 5 45
38.078 0.8921 0.1079 0.0418 6 44
38.998 * . . . . . . . . . 6 43
43.269 * . . . . . . . . . 6 42
43.762 * . . . . . . . . . 6 41
44.255 * . . . . . . . . . 6 40
47.540 0.8698 0.1302 0.0463 7 39
50.300 * . . . . . . . . . 7 38
54.078 * . . . . . . . . . 7 37
56.575 * . . . . . . . . . 7 36
57.528 * . . . . . . . . . 7 35
57.791 * . . . . . . . . . 7 34
59.499 * . . . . . . . . . 7 33
59.992 * . . . . . . . . . 7 32
60.747 0.8427 0.1573 0.0522 8 31
62.324 * . . . . . . . . . 8 30
62.916 * . . . . . . . . . 8 29
68.928 * . . . . . . . . . 8 28
70.209 * . . . . . . . . . 8 27
72.444 * . . . . . . . . . 8 26
73.396 * . . . . . . . . . 8 25
73.922 * . . . . . . . . . 8 24
74.546 * . . . . . . . . . 8 23
76.189 0.8060 0.1940 0.0615 9 22
76.780 * . . . . . . . . . 9 21
77.076 * . . . . . . . . . 9 20
77.897 * . . . . . . . . . 9 19
78.390 * . . . . . . . . . 9 18
81.741 * . . . . . . . . . 9 17
82.990 * . . . . . . . . . 9 16
83.285 * . . . . . . . . . 9 15
83.910 * . . . . . . . . . 9 14
84.961 * . . . . . . . . . 9 13
85.191 * . . . . . . . . . 9 12
88.345 * . . . . . . . . . 9 11
90.251 * . . . . . . . . . 9 10
90.940 * . . . . . . . . . 9 9
93.240 * . . . . . . . . . 9 8
96.033 * . . . . . . . . . 9 7
96.624 * . . . . . . . . . 9 6
96.690 * . . . . . . . . . 9 5
96.920 * . . . . . . . . . 9 4
04.279 * . . . . . . . . . 9 3
10.587 * . . . . . . . . . 9 2
12.263 * . . . . . . . . . 9 1
14.103 * . . . . . . . . . 9 0
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Stratum 2: Preoperative resistive index  0.8
Follow-up, mon Censored Survival Failure Survival SE No. failed No. left
0.000 1.0000 0 0 0 27
2.628 * . . . . . . . . . 0 26
7.392 0.9615 0.0385 0.0377 1 25
13.470 0.9231 0.0769 0.0523 2 24
14.587 * . . . . . . . . . 2 23
16.164 0.8829 0.1171 0.0636 3 22
16.296 0.8428 0.1572 0.0722 4 21
18.760 0.8027 0.1973 0.0792 5 20
24.411 0.7625 0.2375 0.0848 6 19
24.641 0.7224 0.2776 0.0893 7 18
28.386 0.6823 0.3177 0.0929 8 17
33.347 * . . . . . . . . . 8 16
38.834 * . . . . . . . . . 8 15
39.359 0.6368 0.3632 0.0972 9 14
40.016 0.5913 0.4087 0.1004 10 13
41.035 0.5458 0.4542 0.1024 11 12
45.142 * . . . . . . . . . 11 11
47.113 * . . . . . . . . . 11 10
47.836 * . . . . . . . . . 11 9
50.595 * . . . . . . . . . 11 8
52.764 * . . . . . . . . . 11 7
57.429 * . . . . . . . . . 11 6
58.053 0.4548 0.5452 0.1191 12 5
71.425 0.3639 0.6361 0.1253 13 4
71.918 * . . . . . . . . . 13 3
77.076 * . . . . . . . . . 13 2
79.901 * . . . . . . . . . 13 1
87.129 * . . . . . . . . . 13 0
SE, Standard error.
*Denotes censored observations.
